Viewing StudyNCT00105235



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00105235
Status: COMPLETED
Last Update Posted: 2012-12-27
First Post: 2005-03-10

Brief Title: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Organization Data

Organization: National Institute of Allergy and Infectious Diseases NIAID
Class: NIH
Study ID: DAIT ITN024ST
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Immune Tolerance Network ITN NETWORK